03/31/2025
3:35 PM | ANI Pharmaceuticals (Filer)
| Form PRE 14A | |
03/25/2025
3:44 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:47 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
4:17 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:19 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:20 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:22 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:28 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
7:50 PM | ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/11/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ANIP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
03/10/2025
7:28 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:06 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:07 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
6:05 AM | ANI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
3:33 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:11 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:12 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:13 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:14 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:16 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:17 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:19 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:19 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
3:15 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:59 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:20 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:08 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:38 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
6:44 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:57 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:50 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
8:13 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Elon Set to Shock the World by May 1st ? (Ad) Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever…
Yes, even bigger than Tesla or SpaceX. Click here now because after May 1st, it could be too late. |
09/13/2024
3:23 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:44 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
7:29 AM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:21 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
8:51 PM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:26 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:53 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:57 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
4:27 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:30 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:12 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024
6:07 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:37 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:57 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
3:38 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:58 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
5:56 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
6:11 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:46 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:37 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
4:23 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:51 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:21 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
6:34 AM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
5:08 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
3:35 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
6:54 PM | ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:58 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:59 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:02 PM | ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
7:03 PM | ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
6:45 PM | ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
5:14 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
4:21 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:01 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:05 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
3:50 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
4:02 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:02 PM | ANI Pharmaceuticals (Subject)
TANNENBAUM RENEE P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
3:59 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
6:47 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
4:25 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:09 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:26 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:43 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
3:50 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:33 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Most gold “analysts” aren’t really gold analysts… [watch out] (Ad) People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong…
They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.  Go here to learn about my Top Four picks for the coming bull mania. |
04/17/2024
3:19 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
6:59 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:41 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
8:33 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/15/2024
5:28 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:12 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
8:13 PM | ANI Pharmaceuticals (Issuer)
Marken James G. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
8:53 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
Buy ANIP Stock Free ANIP Stock Alerts